A few weeks after Baxter temporarily shuttered its manufacturing plant in Marion, N.C., which was the nation's main supplier of intravenous solutions, 84% of hospital pharmacy workers reported a moderate or critical fluid shortage.
In late September, Hurricane Helene flooded Baxter's site, spawning a national shortage of IV fluids and prompting some hospitals to delay surgeries. The American Society of Health-System Pharmacists surveyed 401 of its members from Oct. 16-25 to assess the severity of the shortage.
Three-fourths of respondents said Baxter is their facility's main supplier of large-volume fluids. The most common mitigation strategies included converting infused medications to injection or intramuscular administration (71% of respondents), rationing fluids for specific clinical indications (60%) and implementing oral hydration protocols (58%).
Among respondents who are in charge of purchasing and inventory management, 47% reported their current inventory of large-volume fluids is down to two weeks' supply or less, the survey found.
On Nov. 7, Baxter said it expects to soon manufacture 85% of its pre-Helene supply of 1-liter units of IV solution — the most common size used by hospitals and clinics. The North Carolina site is currently producing 50% of its normal output of 1-liter IV bags.